Lisa Baumann Kreuziger
It is known that having cancer and receiving treatment for cancer can cause side effects, such as blood clots. The purpose of this research study is to compare the effects, good and/or bad, of two different doses of apixaban (Eliquis®) 2.5 mg or 5 mg on you and your blood clot, to find out which is better in preventing and treating blood clots. In this study, the patient will get either apixaban 2.5 mg or 5 mg twice daily.
Apixaban in Preventing Secondary Cancer Related Venous Thrombosis in Cancer Patients Who Have Completed Anticoagulation Therapy
OPEN TO ACCRUAL